Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Phase Ib/II Trial of Capmatinib Plus Spartalizumab Vs. Spartalizumab Alone in Patients with Pretreated Hepatocellular Carcinoma

JHEP Reports(2024)

Cited 0|Views42
No score
Key words
Capmatinib,Spartalizumab,Hepatocellular carcinoma,MET,anti-programmed death-ligand 1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined